Hartland, KatePu, JunPalmer, MichelleDandapani, SivaramanMoquist, Philip N.Munoz, BenitoDiDone, LouisSchreiber, StuartKrysan, Damian J.2016-02-012015Hartland, Kate, Jun Pu, Michelle Palmer, Sivaraman Dandapani, Philip N. Moquist, Benito Munoz, Louis DiDone, Stuart L. Schreiber, and Damian J. Krysan. 2015. “High-Throughput Screen in Cryptococcus neoformans Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway Signaling.” ACS Infectious Diseases 2 (1): 93-102. doi:10.1021/acsinfecdis.5b00111. http://dx.doi.org/10.1021/acsinfecdis.5b00111.2373-8227http://nrs.harvard.edu/urn-3:HUL.InstRepos:24984021Cryptococcus neoformans is one of the most important human fungal pathogens; however, no new therapies have been developed in over 50 years. Fungicidal activity is crucially important for an effective anticryptococal agent and, therefore, we screened 361,675 molecules against C. neoformans using an adenylate kinase release assay that specifically detects fungicidal activity. A set of secondary assays narrowed the set of hits to molecules that interfere with fungal cell wall integrity and identified three benzothioureas with low in vitro mammalian toxicity and good in vitro anticryptococcal (minimum inhibitory concentration = 4 μg/mL). This scaffold inhibits signaling through the cell wall integrity MAP kinase cascade. Structure–activity studies indicate that the thiocarbonyl moiety is crucial for activity. Genetic and biochemical data suggest that benzothioureas inhibit signaling upstream of the kinase cascade. Thus, the benzothioureas appear to be a promising new scaffold for further exploration in the search for new anticryptococcal agents.en-USArticleCryptococcus neoformansantifungalcell wall integrity pathwayhigh-throughput screeningyeast cell wallmitogen-activated protein kinaseJournal Article2016-02-0110.1021/acsinfecdis.5b00111